Mr. John W Staggers Iii, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 160 N Sheridan Lane, Keyser, WV 26726 Phone: 304-813-7839 Fax: 304-822-4977 |
William Maurice Rhodes, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Rr 3 Box 3266, Keyser, WV 26726 Phone: 304-788-7816 Fax: 304-788-7863 |
Mountain State Home Rehab, Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Rr 5 Box 521, Keyser, WV 26726 Phone: 301-707-3346 Fax: 304-726-4213 |
Mrs. Brooke M Jones, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 146 N Tornado Way, Suite 2, Keyser, WV 26726 Phone: 304-788-7816 Fax: 304-788-7863 |
Mr. Eli W Rhodes, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 196 N Tornado Way, Suite 2, Keyser, WV 26726 Phone: 304-788-7816 Fax: 304-788-7863 |
Progressive Physical Therapy & Rehabilitation Center Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 196 N Tornado Way Ste 2, Keyser, WV 26726 Phone: 304-788-7816 Fax: 304-788-7863 |
Mary J Baniak, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Rr 5 Box 521, Keyser, WV 26726 Phone: 301-707-3346 Fax: 304-726-4213 |
Michael Francis Staggers, M.S., P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: Rr 3 Box 3266, Keyser, WV 26726 Phone: 304-788-7816 Fax: 304-788-7863 |
News Archive
Head and neck cancer is an aggressive type of cancer that often grows back, despite patients undergoing harsh treatments.
The latest research is adding to the growing body of evidence which suggests that moderate amounts of alcohol offer health benefits.
Writing in the latest issue of JAMA Oncology researcher Coral Olazagasti along with her Dr. Nagashree Seetharamu from Zucker School of Medicine at Hofstra, Northwell Health, Hempstead, New York, spoke about her experience being pregnant during the present COVID-19 pandemic. Olazagasti's chronicle is titled "Facing a pandemic while pregnant."
NewLink Genetics Corporation, a biopharmaceutical company primarily focused on discovering, developing and commercializing immunotherapeutic products in oncology, announced today that the company presented preclinical data for NLG919, a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor, at the American Association for Cancer Research 2013 annual meeting.
The sleep study or test is key for diagnosing apnea-hypopnea syndrome but, given its high cost, few resources are earmarked to it. Computer scientist at the University of the Basque Country, Mr Alfredo Burgos, has presented a thesis that aims to solve this problem.
› Verified 8 days ago